Filters close
Released: 9-Apr-2006 1:15 PM EDT
At-risk Drinking Linked With Higher Death Rates
University of California, Los Angeles (UCLA), Health Sciences

Older men who drink as few as two drinks twice a week and also have diseases that could be worsened by alcohol or cause problems with medications taken while drinking alcohol have higher death rates, as compared to men who either drink less or may drink more but don't have such comorbidities.

Released: 24-Feb-2006 8:30 PM EST
How Vitamin D May Fight Back Against Tuberculosis
University of California, Los Angeles (UCLA), Health Sciences

Researchers have unraveled the molecular pathway that runs from sunlight to vitamin D to the body's critical ability to recognize and mount an immune defense against tuberculosis. The findings may also help explain why African American populations appear to be especially susceptible to the disease.

Released: 17-Feb-2006 5:55 PM EST
Pregnancy Predicts STD Testing Among Homeless Youth
University of California, Los Angeles (UCLA), Health Sciences

In the first study of its kind focusing on newly homeless youth, UCLA researchers have found that high-risk sexual behavior did not predict whether these youths were tested for sexually transmitted diseases. Instead, they were tested only when someone became pregnant or got someone pregnant.

Released: 2-Feb-2006 3:15 PM EST
Rapid Diagnosis of Urinary Tract Infections with Novel Biosensor Technology
University of California, Los Angeles (UCLA), Health Sciences

In a recent clinical study researchers used a biosensor to identify correctly the infection-causing gram negative bacteria species in 98 percent of the tested clinical urinary tract infection urine samples.

30-Jan-2006 4:40 PM EST
Testing Method Developed to Assess Safety, Health Risks of Nanomaterials
University of California, Los Angeles (UCLA), Health Sciences

UCLA has developed a new testing strategy to help manufacturers monitor and test the safety and health risks of engineered nanomaterials. Currently no government or industry regulations exist for this emerging technology.

8-Jan-2006 4:35 PM EST
New Method to Track Neuron Cell Death Leading to Alzheimer's Disease
University of California, Los Angeles (UCLA), Health Sciences

Researchers developed a new brain imaging strategy that tracks neural cell loss in the hippocampus, a key memory center of the brain. This cell loss is a hallmark sign of Alzheimer's disease. This new imaging method may offer a new avenue for understanding disease progression as well as offer a new tool for early diagnosis of Alzheimer's disease.

Released: 5-Jan-2006 3:30 PM EST
UCLA Paper Examines How One Disease May Prevent Another
University of California, Los Angeles (UCLA), Health Sciences

Paper suggests that genetic, infectious and metabolic influences should be considered when looking for treatments, particularly in regard to HIV/AIDS.

Released: 19-Dec-2005 10:00 AM EST
Studies Show Benefits of Newborn Screening for ‘Bubble Boy Disease’
University of California, Los Angeles (UCLA), Health Sciences

Two new studies show that newborn screening for Severe Combined Immunodeficiency (SCID) "” a rare, treatable disorder of the immune system commonly known as "bubble boy disease" "” is both cost-effective and could be done accurately using a two tiered testing method.

14-Dec-2005 2:20 PM EST
Microchip Technology for Medical Imaging Biomarkers of Disease
University of California, Los Angeles (UCLA), Health Sciences

A collaboration between scientists have developed a new technology using integrated microfluidics chips for simplifying, lowering the cost and diversifying the types of molecules used to image the biology of disease with the medical imaging technology, Positron Emission Tomography.

8-Dec-2005 1:30 PM EST
Alzheimer Patients Treated With Testosterone Show Improved Quality of Life
University of California, Los Angeles (UCLA), Health Sciences

The first study of the effects of testosterone on mood, behavior and psychological health in men with mild Alzheimer disease finds significant improvements in quality of life, as assessed by caregivers. However, researchers found no significant differences in memory or other cognitive skills, as assessed by tests administered by clinicians.

Released: 8-Dec-2005 8:35 PM EST
Herceptin Plus Chemotherapy Improves Survival in Early Breast Cancer
UCLA Jonsson Comprehensive Cancer Center

Pairing the targeted therapy Herceptin with chemotherapy in patients with early stage breast cancer significantly increases disease-free survival time in women who test positive for a genetic mutation that results in a particularly aggressive form of the disease, according to large, international study.

Released: 6-Dec-2005 7:15 AM EST
Immune Response to HIV Differs Even in Identical Twins
University of California, Los Angeles (UCLA), Health Sciences

In findings illustrating the difficulty of developing an AIDS vaccine, UCLA AIDS Institute researchers report the immune systems in two HIV-positive identical twins responded to the infection in different ways, showing that the body's defenses are random.

1-Dec-2005 8:20 PM EST
Study of Children with Autism Finds Broken Mirror Neuron System
University of California, Los Angeles (UCLA), Health Sciences

New imaging research shows children with autism have virtually no activity in a key part of the brain's mirror neuron system while imitating and observing emotions. Symptoms of autism include difficulties with social interaction.

29-Nov-2005 9:00 AM EST
Psychotherapy for PTSD Among Traumatized Adolescents After Natural Disaster
University of California, Los Angeles (UCLA), Health Sciences

A study spotlights benefits of psychotherapy for children and adolescents after a natural disaster. The study examined response by treated and untreated children following the 1988 Spitak earthquake, and has a lesson for responders to this year's string of natural disasters.

Released: 29-Nov-2005 1:50 PM EST
Colonoscopy with Normal Results Doesn't Reassure IBS Patients
University of California, Los Angeles (UCLA), Health Sciences

A UCLA/VA study found that irritable bowel syndrome (IBS) patients under age 50 who undergo a colonoscopy with normal results aren't reassured about their condition or seem to have an improved quality life due to the procedure ruling out a more serious condition.

22-Nov-2005 9:30 AM EST
Bupropion as Methamphetamine Addiction Treatment Holds Promise
University of California, Los Angeles (UCLA), Health Sciences

A new study suggests the antidepressant bupropion may help treat methamphetamine addiction. No medications presently are approved for treating methamphetamine addicts.

21-Nov-2005 10:00 AM EST
VLBW Infant Mortality Higher at Minority Hospitals
University of California, Los Angeles (UCLA), Health Sciences

Researchers found that infant mortality for black and white infants born at minority-serving hospitals, defined as hospitals where 35 percent of VLBW infants are black, was significantly higher than for black and white infants born at hospitals where fewer than 15 percent of these infants are black.

Released: 22-Nov-2005 9:50 AM EST
Heavy Drinking Falls with Age; Men and Smokers Slower
University of California, Los Angeles (UCLA), Health Sciences

While the researchers noted that heavy drinking declined with age, they found it fell more slowly among men compared with women and among smokers compared with non-smokers.

Released: 14-Nov-2005 6:40 PM EST
Breakdown of Myelin Insulation Implicated in Childhood Disorders
University of California, Los Angeles (UCLA), Health Sciences

An article pinpoints the breakdown of myelin -- the fatty insulation coating the brain's internal connections -- as an important component of childhood developmental disorders and addiction. This is the latest in a series of papers by George Bartzokis implicating myelin as a neural Achilles heel.

7-Nov-2005 8:50 AM EST
Discovery of Molecular Signature Will Aid in Treatment of Brain Cancer Patients
UCLA Jonsson Comprehensive Cancer Center

Researchers at UCLA's Jonsson Cancer have identified key characteristics in certain deadly brain tumors that make them 51 times more likely to respond to a specific class of drugs than tumors in which the molecular signature is absent.

31-Oct-2005 8:35 AM EST
HIV Patients of Low SES Likelier to Die Sooner Than Others
University of California, Los Angeles (UCLA), Health Sciences

HIV patients with a low socioeconomic status are likelier to die much more often than patients with higher levels of wealth and education, a new UCLA study has found. These findings are of concern given the high rates of HIV among patients with low socioeconomic status (SES).

Released: 27-Oct-2005 12:00 AM EDT
$7 in Societal Savings for Every $1 Spent on Drug Abuse Treatment
University of California, Los Angeles (UCLA), Health Sciences

Every dollar spent on substance abuse treatment generates $7 in monetary benefits for society, a new UCLA study shows. The study finds that the average $1,583 cost of substance abuse treatment is offset by monetary benefits such as reduced costs of crime and increased employment earnings totaling $11,487.

Released: 17-Oct-2005 8:50 AM EDT
How Antibody Blocks Prostate Cancer Growth in Animal Models
UCLA Jonsson Comprehensive Cancer Center

Researchers at UCLA's Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy.

Released: 10-Oct-2005 8:40 AM EDT
Limiting Resident Physician Work-Hours Might Save Money
University of California, Los Angeles (UCLA), Health Sciences

Harmful errors in teaching hospitals cost $13.2 billion each year nationwide. But the cost of reducing residents' hours by shifting work to other employees such as nurse practitioners and physician assistants would be much less, $673 million to $1.1 billion per year nationwide.

Released: 6-Oct-2005 3:25 PM EDT
Early Treatment of AMD with Macugen May Preserve Vision
University of California, Los Angeles (UCLA), Health Sciences

The study found that early detection and treatment of age-related macular degeneration with pegaptanib sodium (Macugen) may enable AMD patients to maintain and, in some cases, regain vision.

Released: 3-Oct-2005 1:20 PM EDT
Hepatitis C Drug Helping Patients with Treatment-Induced Anemia
University of California, Los Angeles (UCLA), Health Sciences

A UCLA/VA study found that for Hepatitis C patients who develop treatment-induced anemia due to a key medication, it is more cost-effective to take an additional drug to help prevent anemia, rather than reducing or stopping treatment altogether, which had been the standard approach.

Released: 29-Sep-2005 12:05 PM EDT
Bixby Foundation Donates $5 Million to UCLA School of Public Health
University of California, Los Angeles (UCLA), Health Sciences

The Fred H. Bixby Foundation has donated $5 million to the UCLA School of Public Health to expand the school's research, service and training in the fields of population and family planning.

Released: 28-Sep-2005 4:20 PM EDT
Seniors with Low Age Expectations Often Sedentary
University of California, Los Angeles (UCLA), Health Sciences

A new study found that seniors with the lowest expectations for aging "”that is, for what one can do at an advanced age "” were the most likely to lead sedentary lifestyles.

Released: 28-Sep-2005 8:35 AM EDT
Impact of Somatization on Health Resources Usage in IBS Patients
University of California, Los Angeles (UCLA), Health Sciences

Even though there are definitive guidelines to diagnose IBS through simple blood tests, many irritable bowel syndrome (IBS) patients have additional procedures and surgeries that rarely result in relief or any additional diagnostic findings.

Released: 15-Sep-2005 2:25 PM EDT
UCLA Neurosurgery to Give Jay Leno Dangerfield Legacy Award
University of California, Los Angeles (UCLA), Health Sciences

The Division of Neurosurgery at UCLA Medical Center will present "Tonight Show" host Jay Leno with the first Rodney Respect award Oct. 20 at the division's inaugural Visionary Ball fundraiser in Beverly Hills.

9-Sep-2005 8:30 AM EDT
UCLA/NIH Scientists Block Viruses from Entering Cells
University of California, Los Angeles (UCLA), Health Sciences

First identified more than 20 years ago at UCLA, defensins are peptides naturally produced by the immune system to ward off viruses. However, it was unclear how defensins worked. Now UCLA and NIH scientists have discovered that a specific defensin called retrocyclin-2 (RC2) binds to carbohydrate-containing proteins in cell membranes.

Released: 7-Sep-2005 11:00 AM EDT
UCLA Experts Can Address Hurricane's Aftermath
University of California, Los Angeles (UCLA), Health Sciences

UCLA experts are available to describe the challenges facing forensic pathologists in identifying casualties, and to discuss the public health, psychological, economic and structural/rebuilding effects of Hurricane Katrina.

1-Sep-2005 12:00 PM EDT
Study Helps ER Physicians Identify Previously Undetectable Spinal Injuries
University of California, Los Angeles (UCLA), Health Sciences

Patients with a cervical spine injury may harbor additional spinal damage not visible on regular x-rays. Researchers found more than a third of patients who were thought to have low-risk injuries actually have additional damage that may include significant fractures with the potential to produce serious spinal problems if not detected and treated properly.

25-Aug-2005 2:50 PM EDT
Statin Treatment within First 24 Hours After Heart Attack Cut Mortality
University of California, Los Angeles (UCLA), Health Sciences

Treatment with a statin drug within the first 24-hours after a heart attack reduced in-hospital mortality rates by over 50 percent according to a new UCLA study.

Released: 24-Aug-2005 11:40 AM EDT
UCLA Promotes Peace Through Science in Middle East
University of California, Los Angeles (UCLA), Health Sciences

The Integrated Substance Abuse Programs at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA will convene a four-day meeting of health officials from more than two dozen Middle East nations and their neighbors Sept. 4"“8 in Istanbul, Turkey.

Released: 24-Aug-2005 11:35 AM EDT
Comparison of Cocaine, Methamphetamine ‘Highs’ Finds Differences
University of California, Los Angeles (UCLA), Health Sciences

Investigators examining responses to cocaine and methamphetamine use find distinct differences in onset, pattern and duration. Subjective, or self-reported, responses to cocaine peak and decline more rapidly than those of methamphetamine, the study shows.

9-Aug-2005 8:40 AM EDT
Researchers Identify Enzyme Linked to Childhood Blindness
University of California, Los Angeles (UCLA), Health Sciences

In findings that could lead to curing some forms of congenital blindness through gene therapy, researchers at UCLA have discovered that RPE65, a gene missing in infants born with the blinding disease Leber congenital amaurosis, is also a key enzyme in the visual cycle.

1-Aug-2005 2:00 PM EDT
Study Correlates Actual Brain Activity with fMRI Signals
University of California, Los Angeles (UCLA), Health Sciences

Functional MRI has become a preferred method for measuring brain activity in research and clinical work, but until now no one has actually correlated real brain electrical activity to blood flow activity measured by fMRI. Neuroscientists at UCLA and the Weizmann Institute are the first.

Released: 15-Jul-2005 8:45 AM EDT
ULCA Scientists Find Potential Celebrex Target in Lung Cancer
UCLA Jonsson Comprehensive Cancer Center

A product produced by lung cancer tumors fuels the cells that suppress immune function in patients and may be a target for Celebrex therapy, giving oncologists another weapon to fight cancer, according to a study by researchers at UCLA's Jonsson Cancer Center.

7-Jul-2005 2:40 PM EDT
Major Heart Failure Quality of Care Variations Found in U.S. Hospitals
University of California, Los Angeles (UCLA), Health Sciences

UCLA investigators found large gaps and variations in treatment for heart failure in U.S. hospitals based on four standard quality measures. Performance of these measures is closely linked to heart failure patients' risk of rehospitalization and death.

5-Jul-2005 3:35 PM EDT
How Deadly Nipah Virus Infects Cells; Discovery Could Halt Bioterrorism Use
University of California, Los Angeles (UCLA), Health Sciences

UCLA scientists have discovered how the deadly Nipah virus infiltrates human cells to cause encephalitis. Designated as a potential bioterrorism agent by the National Biodefense Research Agenda, the virus exploits a protein essential to embryonic development to enter cells and launch its attack.

29-Jun-2005 8:40 AM EDT
Risperidone Safe, Effective as Intermediate Term Treatment for Autism
University of California, Los Angeles (UCLA), Health Sciences

A multi-site research group working under contract with NIMH finds that risperidone, one of the newer anti-psychotic medications, is safe and effective for controlling aggressive and violent behavior in autistic children with minimal side effects for up to six months.

27-Jun-2005 2:55 PM EDT
Newborn Dolphins, Killer Whales Stay Active 24/7 During First Months
University of California, Los Angeles (UCLA), Health Sciences

A study finds that unlike other mammals, newborn dolphins and killer whales remain awake and active 24/7 during the first weeks of life when critical development takes place.

21-Jun-2005 9:05 AM EDT
Japanese Doctors Involve Families More than U.S. Doctors
University of California, Los Angeles (UCLA), Health Sciences

Medical residents in Japan are more likely to involve patients' families in end-of-life decision making -- and to favor informing family members over the patients first -- than their United States counterparts, who prefer dealing directly with the patient.

20-Jun-2005 12:30 PM EDT
Single Cell Recognition Research Finds a Halle Berry Neuron
University of California, Los Angeles (UCLA), Health Sciences

UCLA and Caltech researchers report that single brain cells are much more powerful than previously thought. Single neurons are able to distinguish people, such as actress Halle Berry, places and things, and recognize them in varying contexts and even abstract form.

8-Jun-2005 3:50 PM EDT
Enhancing the Innate Immune System Protects Brain Against Alzheimer's
University of California, Los Angeles (UCLA), Health Sciences

Researchers discovered that some patients with Alzheimer's disease have an immune system defect making it difficult to clean away amyloid-beta waste products in the brain. This may lead to over-saturation of the brain with amyloid beta, which form amyloid plaques, the definitive hallmark of Alzheimer's disease.

Released: 6-Jun-2005 1:30 PM EDT
New Method of Growth Hormone Dosing Improves Height
University of California, Los Angeles (UCLA), Health Sciences

A randomized study found that a new dosing paradigm can improve height outcomes in the treatment of children who have short stature due to growth hormone deficiency and idiopathic short stature.

1-Jun-2005 8:45 AM EDT
Unique Recordings of Brain Cell Activity Reveal Nature of Narcolepsy
University of California, Los Angeles (UCLA), Health Sciences

Writing in the upcoming edition of Neuron, researchers pinpoint the electrical "signature" of hypocretin brain cells, whose loss triggers narcolepsy, and find these cells are active during excitement generated by positive emotions and play a key role in maintaining brain alertness.

20-May-2005 1:10 PM EDT
Significant Benefits, Less Organ Rejection Using Immunosuppressive Combination Therapy
University of California, Los Angeles (UCLA), Health Sciences

Amid the debate over which combination of immunosuppressive agents works best in helping patients fight off rejection of their new heart after transplant surgery, a new study showed that one particular combination using tacrolimus had significant anti-rejection benefits for heart transplant patients over other combinations.

19-May-2005 9:00 AM EDT
Men with Spouses, Partners Fare Better After Prostate Cancer Treatment
University of California, Los Angeles (UCLA), Health Sciences

Being married or in a relationship significantly improves quality of life for prostate cancer patients following treatment, according to a study by researchers at UCLA's Jonsson Cancer Center and the Department of Urology.



close
0.25023